Pharmacodynamics and organ storage of hydroxyethyl starch in acute hemodilution in pigs: Influence of molecular weightand degree of substitution

Intensive Care Medicine

Volumn 33, Issue 9, 2007, Pages 1637-1644

  Eisenbach, Christoph ^a   Schönfeld, Alexander H ^b   Vogt, Norbert ^c   Wente, Moritz N ^a   Encke, Jens ^a   Stremmel, Wolfgang ^a   Martin, Eike ^a   Pfenninger, Ernst ^d   Weigand, Markus A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Evangelisches und Johanniter Klinikum Niederrhein   (Germany)

^c MARTIN LUTHER KRANKENHAUS   (Germany)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

Clearance; Degree of substitution; Hemodynamics; Hydroxyethyl starch; Molecular weight; Organ storage

Indexed keywords

HETASTARCH;

ARTICLE; BLEEDING; BLOOD; COMPARATIVE STUDY; HEMODILUTION; KIDNEY; LIVER; LUNG; LYMPH NODE; MICROCIRCULATION; MOLECULAR WEIGHT; NONHUMAN; ORGAN PRESERVATION; PHARMACODYNAMICS; PLASMA CLEARANCE; PLASMA VOLUME; PROSPECTIVE STUDY; SPLEEN; STATISTICAL SIGNIFICANCE; STEADY STATE; SWINE; TISSUE PRESERVATION; URINE;

ANIMALS; BLOOD VOLUME; HEMODILUTION; HEMOGLOBINS; HETASTARCH; MODELS, ANIMAL; MOLECULAR WEIGHT; OXYGEN; PLASMA SUBSTITUTES; PROSPECTIVE STUDIES; RANDOM ALLOCATION; SWINE; TISSUE DISTRIBUTION; URINATION;

EID: 34548160019     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0716-x     Document Type: Article

References (36)

1. Lundberg JS, Perl TM, Wiblin T, Costigan MD, Dawson J, Nettleman MD, Wenzel RP (1998) Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit Care Med 26:1020-1024
2. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377
3. Grönwall A (1957) Dextran and its use in colloidal infusion solutions. Almquist and Wiksell, Uppsala, pp 10-21
4. Thompson WL (1980) Hydroxyethyl starch. Dev Biol Stand 48:259-266
5. Mishler JMT (1984) Synthetic plasma volume expanders: their pharmacology, safety and clinical efficacy. Clin Haematol 13:75-92
6. Treib J, Baron JF, Grauer MT, Strauss RG (1999) An international view of hydroxyethyl starches. Intensive Care Med 25:258-268
7. Lenz K, Schimetta W, Polz W, Kroll W, Gruy-Kapral C, Magometschnigg D (2000) Intestinal elimination of hydroxyethyl starch? Intensive Care Med 26:733-739
8. Hulse JD, Yacobi A (1983) Hetastarch: an overview of the colloid and its metabolism. Drug Intell Clin Pharm 17:334-341
9. Leuschner J, Opitz J, Winkler A, Scharpf R, Bepperling F (2003) Tissue storage of 14C-labelled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intravenous administration to rats. Drugs R D 4:331-338
10. Hankeln K, Radel C, Beez M, Laniewski P, Bohmert F (1989) Comparison of hydroxyethyl starch and lactated Ringer's solution on hemodynamics and oxygen transport of critically ill patients in prospective crossover studies. Crit Care Med 17:133-135
11. Haupt MT, Rackow EC (1982) Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Crit Care Med 10:159-162
12. Rackow EC, Falk JL, Fein IA, Siegel JS, Packman MI, Haupt MT, Kaufman BS, Putnam D (1983) Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 11:839-850
13. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247-2256
14. Boldt J, Muller M, Mentges D, Papsdorf M, Hempelmann G (1998) Volume therapy in the critically ill: Is there a difference? Intensive Care Med 24:28-36
15. Winkelmayer WC, Glynn RJ, Levin R, Avorn J (2003) Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int 64:1046-1049
16. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357:911-916
17. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P (1996) Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348:1620-1622
18. Gosling P, Rittoo D, Manji M, Mahmood A, Vohra R (2001) Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet 358:581
19. Deman A, Peeters P, Sennesael J (1999) Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multicentre analysis. Nephrol Dial Transplant 14:1517-1520
20. Kumle B, Boldt J, Piper S, Schmidt C, Suttner S, Salopek S (1999) The influence of different intravascular volume replacement regimens on renal function in the elderly. Anesth Analg 89:1124-1130
21. Boldt J, Brenner T, Lehmann A, Lang J, Kumle B, Werling C (2003) Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin. Intensive Care Med 29:763-769
22. Appel W, Wirmer V, Sprengard D (1968) Quantitative micro determination of dextran. I. In body fluids. Z Klin Chem Klin Biochem 6:452-458
23. Ahnefeld FW, Halmagyi M, Uberla K (1965) Studies for the evaluation of colloidal volume substitution. Anaesthesist 14:137-143
24. Linko K, Makelainen A (1989) Cardiorespiratory function after replacement of blood loss with hydroxyethyl starch 120, dextran-70, and Ringer's acetate in pigs. Crit Care Med 17:1031-1035
25. Jungheinrich C, Neff TA (2005) Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 44:681-699
26. Kohler H, Zschiedrich H, Clasen R, Linfante A, Gamm H (1982) The effects of 500 ml 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure and renal function in human volunteers. Anaesthesist 31:61-67
27. Messmer K, Jesch F (1978) Blood volume replacement and hemodilution with hydroxyethyl starch. Infusionsther Klin Ernahr 5:169-177
28. Neumann R, Worek FS, Blumel G, Zimmermann GJ, Fehm HL, Pfeiffer UJ (1989) Cortisol deficiency in metomidate anesthetized bacteremic pigs: results in circulatory failure - beneficial effect of cortisol substitution. Acta Anaesthesiol Scand 33:379-384
29. Weidler B, Bormann B von, Sommermeyer K, Lohmann E, Peil J, Hempelmann G (1991) Pharmacokinetic parameters as criteria for clinical use of hydroxyethyl starch preparations. Arzneimittelforschung 41:494-498
30. Kalhorn TF, Yacobi A, Sum CY (1984) Biliary excretion of hydroxyethyl starch in man. Biomed Mass Spectrum 11:164-166
31. Thompson WL, Fukushima T, Rutherford RB, Walton RP (1970) Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch. Surg Gynecol Obstet 131:965-972
32. Dienes HP, Gerharz CD, Wagner R, Weber M, John HD (1986) Accumulation of hydroxyethyl starch (HES) in the liver of patients with renal failure and portal hypertension. J Hepatol 3:223-227
33. Parth E, Jurecka W, Szepfalusi Z, Schimetta W, Gebhart W, Scheiner O, Kraft D (1992) Histological and immunohistochemical investigations of hydroxyethyl-starch deposits in rat tissues. Eur Surg Res 24:13-21
34. Jurecka W, Szepfalusi Z, Parth E, Schimetta W, Gebhart W, Scheiner O, Kraft D (1993) Hydroxyethylstarch deposits in human skin: a model for pruritus? Arch Dermatol Res 285:13-19
35. Sirtl C, Laubenthal H, Zumtobel V, Kraft D, Jurecka W (1999) Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. Br J Anaesth 82:510-515
36. Reinhart K, Bloos F, Engel C, For the German Competence Network Sepsis (2006) Hydroxyethyl starch and ringer's lactate for fluid resuscitation in patients with severe sepsis: result from the VISEP study. Intensive Care Med 32:S213